Emergent BioSolutions (EBS) Fails to deliver data

Key failure to deliver metrics for Emergent BioSolutions :

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: C$0.01 M
• Last 3 months FTD volume: C$0.66 M
• Last 12 months FTD volume: C$4.47 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Emergent BioSolutions (EBS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Emergent BioSolutions (EBS) - since 2013

Emergent BioSolutions (EBS) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Pfizer PFE	C$56.21 M	C$0.12 B	🇺🇸 USA
Merck MRK	C$36.21 M	C$0.14 B	🇺🇸 USA
GSK plc GSK	C$48.95 M	C$0.36 B	🇬🇧 UK
Soligenix SNGX	C$0.46 M	C$14.16 M	🇺🇸 USA
SIGA Technologies SIGA	C$0.11 M	C$1.07 M	🇺🇸 USA
Celldex Therapeutics CLDX	C$6.56 M	C$10.98 M	🇺🇸 USA
Teva Pharmaceutical Industries TEVA	C$53.08 M	C$87.14 M	🇮🇱 Israel